122 Chapter 4 Supplementary Table 2: Between-group immunological event comparisons (excluding people with a clinical diagnosis) Variable Narcolepsy type 1 (N = 176) Narcolepsy type 2 or idiopathic hypersomnia (N = 44) Odds ratio (95% CI) Effect size Corrected p-value Infections & influenza vaccinations N Percentage of N N Percentage of N Total immunological event prevalence 176 43.8% 44 45.5% 0.93 (0.48-1.81) 0.0137 0.9225 Distribution of immunological events 80 Flu: 11.3% EBV: 12.5% Other respiratory infection: 10.0% Other non-respiratory infections: 12.5% H1N1 influenza vaccination: 41.3% Other years/ unspecified yearly: 12.5% 20 Flu: 5.0% EBV: 30.0% Other respiratory infection: 35.0% Other non-respiratory infections: 15.0% H1N1 influenza vaccination: 0.0% Other years/ unspecified yearly: 15.0% - 0.4331 0.0043# Infections Total Infection prevalence 136 27.2% 28 60.7% 0.24 (0.100.56) 0.2683 0.0043 Flu infection prevalence 136 6.6% 28 3.6% 1.91 (0.2315.74) 0.0479 1.0000# EBV infection prevalence 136 7.4% 28 21.4% 0.29 (0.100.88) 0.1785 0.0544
RkJQdWJsaXNoZXIy MjY0ODMw